DK0517797T3 - Anvendelse af D-vitaminanaloger i behandlingen af akne - Google Patents

Anvendelse af D-vitaminanaloger i behandlingen af akne

Info

Publication number
DK0517797T3
DK0517797T3 DK91905594.7T DK91905594T DK0517797T3 DK 0517797 T3 DK0517797 T3 DK 0517797T3 DK 91905594 T DK91905594 T DK 91905594T DK 0517797 T3 DK0517797 T3 DK 0517797T3
Authority
DK
Denmark
Prior art keywords
pct
vitamin
acne
analogues
treatment
Prior art date
Application number
DK91905594.7T
Other languages
Danish (da)
English (en)
Inventor
Wagn Ole Godtfredsen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of DK0517797T3 publication Critical patent/DK0517797T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK91905594.7T 1990-03-01 1991-02-25 Anvendelse af D-vitaminanaloger i behandlingen af akne DK0517797T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909004544A GB9004544D0 (en) 1990-03-01 1990-03-01 Novel treatment ii

Publications (1)

Publication Number Publication Date
DK0517797T3 true DK0517797T3 (da) 1995-11-13

Family

ID=10671792

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91905594.7T DK0517797T3 (da) 1990-03-01 1991-02-25 Anvendelse af D-vitaminanaloger i behandlingen af akne

Country Status (11)

Country Link
US (1) US5292727A (de)
EP (1) EP0517797B1 (de)
JP (1) JPH05504959A (de)
AT (1) ATE127691T1 (de)
AU (1) AU7458891A (de)
DE (1) DE69113029T2 (de)
DK (1) DK0517797T3 (de)
ES (1) ES2079063T3 (de)
GB (1) GB9004544D0 (de)
GR (1) GR3017413T3 (de)
WO (1) WO1991012807A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362719A (en) * 1990-03-01 1994-11-08 Leo Pharmaceutical Products, Ltd. A/S Lovens Kemiske Fabrik Produktionsaktieselskab) Use of vitamin-D analogues in the treatment of acne
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
PE28297A1 (es) * 1995-01-26 1997-08-20 Hoffmann La Roche Empleo dermatologico de derivados de vitamina d
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
CA2312731A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin d3 derivatives
EP1051974A4 (de) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Vitamin-d3-derivate enthaltende lotionen
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
EP2455083B1 (de) 1999-04-23 2013-09-18 Leo Pharma A/S Pharmazeutische Zusammensetzung zur Anwendung auf der Haut enthaltend Calcipotriol und Betamethason zur Behandlung von Psoriasis
US6893658B1 (en) 1999-08-31 2005-05-17 Chugai Seiyaku Kabushiki Kaisha Soft capsules
CA2425367A1 (en) * 2000-08-30 2003-04-07 Chugai Seiyaku Kabushiki Kaisha Oct formulations
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
NZ555282A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 17,20(z)-dehydro vitamin D analogs and their uses
ES2407407T3 (es) * 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PL2679228T3 (pl) 2006-06-21 2018-07-31 Opko Ireland Global Holdings, Ltd. Terapia z użyciem środka do uzupełniania witaminy D i środka do zastępowania hormonami witaminy D
MX2009002337A (es) * 2006-08-29 2009-03-20 Teva Pharma Composiciones farmacologicamente estables que incluyen compuestos que contienen vitamina d y corticosteroides con compatibilidad con bajo ph.
WO2008073174A2 (en) * 2006-09-08 2008-06-19 The Regents Of The University Of California Antimicrobial therapy
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
EP3542792B1 (de) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Kontrollierte freisetzung 25-hydroxyvitamin d
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
ES2403107T3 (es) 2007-04-25 2013-05-14 Cytochroma Inc. Método de tratamiento de insuficiencia y deficiencia de vitamina D
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
US7727562B2 (en) * 2007-06-21 2010-06-01 Blackman Steven T Liquid compositions containing solubilized benzoyl peroxide
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
HUE048464T2 (hu) 2010-03-29 2020-07-28 Opko Ireland Global Holdings Ltd Módszerek és készítmények mellékpajzsmirigy szintjének csökkentésére
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
JP2014144929A (ja) * 2013-01-29 2014-08-14 Daiichi Sankyo Healthcare Co Ltd ビタミン類を含有するニキビの予防又は治療用組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CA2957240A1 (en) 2014-08-07 2016-02-11 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JPS6218A (ja) * 1985-03-14 1987-01-06 Chugai Pharmaceut Co Ltd 皮膚疾患治療用組成物
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
EP0398217B1 (de) * 1989-05-18 1994-01-12 F. Hoffmann-La Roche Ag Dehydrocholecalciferolderivate

Also Published As

Publication number Publication date
DE69113029D1 (de) 1995-10-19
GR3017413T3 (en) 1995-12-31
DE69113029T2 (de) 1996-03-07
ATE127691T1 (de) 1995-09-15
GB9004544D0 (en) 1990-04-25
EP0517797A1 (de) 1992-12-16
EP0517797B1 (de) 1995-09-13
JPH05504959A (ja) 1993-07-29
WO1991012807A1 (en) 1991-09-05
ES2079063T3 (es) 1996-01-01
AU7458891A (en) 1991-09-18
US5292727A (en) 1994-03-08

Similar Documents

Publication Publication Date Title
DK0517797T3 (da) Anvendelse af D-vitaminanaloger i behandlingen af akne
ES2055845T3 (es) Composicion farmaceutica para el tratamiento de la osteoporosis.
NO983266L (no) Distribuert Behandling
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
DK0584136T3 (da) Bestemmelse af peptidmotiver på MHC-molekyler
AU5561686A (en) Method of increasing bone mass
ES2121793T3 (es) Composiciones de uso local para la administracion transdermica de derivados profarmacos de morfina.
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
ES2084390T3 (es) Comprimidos de liberacion controlada, de varias capas, que contienen tanto naproxen como sal sodica de naproxen.
NZ211925A (en) Kit for use in treatment of osteoporosis including a polyphosphonate
NZ318430A (en) Synergistic combination of VDR ligand(s) and retinoids and their use in the treatment of cell hyperproliferation.
DK1632248T3 (da) Anti-interleukin-9-antistof eller anti-interleukin-9-receptor-antistof til behandling af bronkial overfølsomhed
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
FI962550A (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
NZ326345A (en) Composition containing diosgenin
ES2068388T3 (es) Moleculas de receptor de hormona de la glucoproteina.
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
ES2153689T3 (es) Pastilla de jabon antiseptico.
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
ES2185698T3 (es) Composicion de tratamiento anti-acne de la piel.
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
BR9708511A (pt) Utilização de compostos utilização de ácido 6-[3-(1-adamantil)-4-metoxifenil]-2naftóico e utilização do ácido 6-[3-(1-adamantil)-4-hidroxifenil]-2-naftóico
ES2072005T3 (es) Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel.